48
Views
59
CrossRef citations to date
0
Altmetric
Article

The p85α Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates c-Jun N-Terminal Kinase-Mediated Insulin Resistance

, , , , , , , & show all
Pages 2830-2840 | Received 15 Jan 2007, Accepted 18 Jan 2007, Published online: 27 Mar 2023

REFERENCES

  • Antonetti, D. A., P. Algenstaedt, and C. R. Kahn. 1996. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell. Biol. 16:2195–2203.
  • Backer, J. M., M. G. Myers, Jr., S. E. Shoelson, D. J. Chin, X. J. Sun, M. Miralpeix, P. Hu, B. Margolis, E. Y. Skolnik, J. Schlessinger, and M. F. White. 1992. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:3469–3479.
  • Bandyopadhyay, G. K., J. G. Yu, J. Ofrecio, and J. M. Olefsky. 2005. Increased p85/55/50 expression and decreased phosphatidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54:2351–2359.
  • Baud, V., Z. G. Liu, B. Bennett, N. Suzuki, Y. Xia, and M. Karin. 1999. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13:1297–1308.
  • Beeton, C. A., P. Das, M. D. Waterfield, and P. R. Shepherd. 1999. The SH3 and BH domains of the p85α adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function. Mol. Cell. Biol. Res. Commun. 1:153–157.
  • Bertagnolo, V., F. Brugnoli, M. Marchisio, C. Celeghini, C. Carini, and S. Capitani. 2004. Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. Cell Signal. 16:423–433.
  • Block, G. D., J. Locker, W. C. Bowen, B. E. Petersen, S. Katyal, S. C. Strom, T. Riley, T. A. Howard, and G. K. Michalopoulos. 1996. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGFα in a chemically defined (HGM) medium. J. Cell Biol. 132:1133–1149.
  • Brachmann, S. M., C. M. Yballe, M. Innocenti, J. A. Deane, D. A. Fruman, S. M. Thomas, and L. C. Cantley. 2005. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol. Cell. Biol. 25:2593–2606.
  • Reference deleted.
  • Carpenter, C. L., and L. C. Cantley. 1996. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:153–158.
  • Dhand, R., K. Hara, I. Hiles, B. Bax, I. Gout, G. Panayotou, M. J. Fry, K. Yonezawa, M. Kasuga, and M. D. Waterfield. 1994. PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13:511–521.
  • Fidyk, N. J., and R. A. Cerione. 2002. Understanding the catalytic mechanism of GTPase-activating proteins: demonstration of the importance of switch domain stabilization in the stimulation of GTP hydrolysis. Biochemistry 41:15644–15653.
  • Fruman, D. A., L. C. Cantley, and C. L. Carpenter. 1996. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85α gene. Genomics 37:113–121.
  • Fruman, D. A., F. Mauvais-Jarvis, D. A. Pollard, C. M. Yballe, D. Brazil, R. T. Bronson, C. R. Kahn, and L. C. Cantley. 2000. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α. Nat. Genet. 26:379–382.
  • Gallo, K. A., and G. L. Johnson. 2002. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell. Biol. 3:663–672.
  • Garcia, Z., V. Silio, M. Marques, I. Cortes, A. Kumar, C. Hernandez, A. I. Checa, A. Serrano, and A. C. Carrera. 2006. A P13K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis. EMBO J. 25:4740–4751.
  • He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
  • Hill, K. M., Y. Huang, S. C. Yip, J. Yu, J. E. Segall, and J. M. Backer. 2001. N-terminal domains of the class Ia phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling. J. Biol. Chem. 276:16374–16378.
  • Hirashima, Y., K. Tsuruzoe, S. Kodama, M. Igata, T. Toyonaga, K. Ueki, C. R. Kahn, and E. Araki. 2003. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 179:253–266.
  • Hirosumi, J., G. Tuncman, L. Chang, C. Z. Gorgun, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature 420:333–336.
  • Hotamisligil, G. S., P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665–668.
  • Reference deleted.
  • Hu, F. B., J. E. Manson, M. J. Stampfer, G. Colditz, S. Liu, C. G. Solomon, and W. C. Willett. 2001. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345:790–797.
  • Reference deleted.
  • Inukai, K., M. Anai, E. Van Breda, T. Hosaka, H. Katagiri, M. Funaki, Y. Fukushima, T. Ogihara, Y. Yazaki, Kikuchi, Y. Oka, and T. Asano. 1996. A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK Is generated by alternative splicing of the p85α gene. J. Biol. Chem. 271:5317–5320.
  • Iordanov, M. S., D. Pribnow, J. L. Magun, T. H. Dinh, J. A. Pearson, S. L. Chen, and B. E. Magun. 1997. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA. Mol. Cell. Biol. 17:3373–3381.
  • Jiménez, C., R. A. Portela, M. Mellado, J. M. Rodriguez-Frade, J. Collard, A. Serrano, A. C. Martinez, J. Avila, and A. C. Carrera. 2000. Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J. Cell Biol. 151:249–262.
  • Kang, H., H. Schneider, and C. E. Rudd. 2002. Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110. J. Biol. Chem. 277:912–921.
  • Kuhn, T. B., P. J. Meberg, M. D. Brown, B. W. Bernstein, L. S. Minamide, J. R. Jensen, K. Okada, E. A. Soda, and J. R. Bamburg. 2000. Regulating actin dynamics in neuronal growth cones by ADF/cofilin and rho family GTPases. J. Neurobiol. 44:126–144.
  • Luo, J., S. J. Field, J. Y. Lee, J. A. Engelman, and L. C. Cantley. 2005. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J. Cell Biol. 170:455–464.
  • Luo, J., J. R. McMullen, C. L. Sobkiw, L. Zhang, A. L. Dorfman, M. C. Sherwood, M. N. Logsdon, J. W. Horner, R. A. Depinho, S. Izumo, and L. C. Cantley. 2005. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol. Cell. Biol. 25:9491–9502.
  • Mauvais-Jarvis, F., K. Ueki, D. A. Fruman, M. F. Hirshman, K. Sakamoto, L. J. Goodyear, M. Iannacone, D. Accili, L. C. Cantley, and C. R. Kahn. 2002. Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Investig. 109:141–149.
  • Miller, B. S., U. T. Shankavaram, M. J. Horney, A. C. Gore, D. T. Kurtz, and S. A. Rosenzweig. 1996. Activation of cJun NH2-terminal kinase/stress-activated protein kinase by insulin. Biochemistry 35:8769–8775.
  • Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147–1157.
  • Miyake, K., W. Ogawa, M. Matsumoto, T. Nakamura, H. Sakaue, and M. Kasuga. 2002. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Investig. 110:1483–1491.
  • Mokdad, A. H., E. S. Ford, B. A. Bowman, W. H. Dietz, F. Vinicor, V. S. Bales, and J. S. Marks. 2003. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J. Am. Med. Assoc. 289:76–79.
  • Musacchio, A., L. C. Cantley, and S. C. Harrison. 1996. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85α subunit. Proc. Natl. Acad. Sci. USA 93:14373–14378.
  • Okkenhaug, K., and B. Vanhaesebroeck. 2001. New responsibilities for the PI3K regulatory subunit p85α. Sci. STKE 2001:PE1. https://doi.org/10.1126/stke.2001.65.pe1.
  • Ozcan, U., Q. Cao, E. Yilmaz, A. H. Lee, N. N. Iwakoshi, E. Ozdelen, G. Tuncman, C. Gorgun, L. H. Glimcher, and G. S. Hotamisligil. 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457–461.
  • Pirola, L., A. M. Johnston, and E. Van Obberghen. 2004. Modulation of insulin action. Diabetologia 47:170–184.
  • Postic, C., and M. A. Magnuson. 2000. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 26:149–150.
  • Reaven, G. M. 2005. Why syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab. 1:9–14.
  • Shaw, M., P. Cohen, and D. R. Alessi. 1998. The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J. 336(Pt. 1):241–246.
  • Sinha, R., G. Fisch, B. Teague, W. V. Tamborlane, B. Banyas, K. Allen, M. Savoye, V. Rieger, S. Taksali, G. Barbetta, R. S. Sherwin, and S. Caprio. 2002. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N. Engl. J. Med. 346:802–810.
  • Srinivasan, S., M. Ohsugi, Z. Liu, S. Fatrai, E. Bernal-Mizrachi, and M. A. Permutt. 2005. Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3beta in mouse insulinoma cells. Diabetes 54:968–975.
  • Taniguchi, C. M., B. Emanuelli, and C. R. Kahn. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell. Biol. 7:85–96.
  • Taniguchi, C. M., T. Kondo, M. Sajan, J. Luo, R. Bronson, T. Asano, R. Farese, L. C. Cantley, and C. R. Kahn. 2006. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKCλ/ζ. Cell Metab. 3:343–353.
  • Taniguchi, C. M., T. T. Tran, T. Kondo, J. Luo, K. Ueki, L. C. Cantley, and C. R. Kahn. 2006. Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN. Proc. Natl. Acad. Sci. USA 103:12093–12097.
  • Taniguchi, C. M., K. Ueki, and R. Kahn. 2005. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Investig. 115:718–727.
  • Terauchi, Y., J. Matsui, J. Kamon, T. Yamauchi, N. Kubota, K. Komeda, S. Aizawa, Y. Akanuma, M. Tomita, and T. Kadowaki. 2004. Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85α phosphoinositide 3-kinase. Diabetes 53:2261–2270.
  • Tolias, K. F., L. C. Cantley, and C. L. Carpenter. 1995. Rho family GTPases bind to phosphoinositide kinases. J. Biol. Chem. 270:17656–17659.
  • Ueki, K., P. Algenstaedt, F. Mauvais-Jarvis, and C. R. Kahn. 2000. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85α regulatory subunit. Mol. Cell. Biol. 20:8035–8046.
  • Ueki, K., D. A. Fruman, C. M. Yballe, M. Fassaur, J. Klein, T. Asano, L. C. Cantley, and C. R. Kahn. 2003. Positive and negative roles of p85α and p85β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J. Biol. Chem. 278:48453–48466.
  • Ueki, K., C. M. Yballe, S. M. Brachmann, D. Vicent, J. M. Watt, C. R. Kahn, and L. C. Cantley. 2002. Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 99:419–424.
  • Usui, I., T. Imamura, J. Huang, H. Satoh, and J. M. Olefsky. 2003. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 278:13765–13774.
  • Virkamäki, A., K. Ueki, and C. R. Kahn. 1999. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Investig. 103:931–943.
  • Zheng, Y., S. Bagrodia, and R. A. Cerione. 1994. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 269:18727–18730.
  • Zhu, T., E. L. Goh, D. LeRoith, and P. E. Lobie. 1998. Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J. Biol. Chem. 273:33864–33875.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.